Coloring together

A preexisting desire to work together and mutual interest in stem cell biology being developed at Harvard University led Atlas Venture and Third Rock Ventures to form a company together for the first time last week.

The firms co-led Magenta Therapeutics’ $48.5 million series A round, which included participation by GV, Access Industries and Partners Innovation Fund...